-
1
-
-
0003964363
-
-
American Cancer Society. Atlanta: American Cancer Society
-
American Cancer Society. Cancer facts & figures 2007. Atlanta: American Cancer Society, 2007.
-
(2007)
Cancer Facts & Figures 2007
-
-
-
2
-
-
24644457747
-
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: A multicenter study of the Gruppo Oncologico Dell'Italia Meridionale
-
Colucci G, Gebbia V, Paoletti G, Giuliani F, Caruso M, Gebbia N, Cartenì G, Agostara B, Pezzella G, Manzione L, Borsellino N, Misino A, et al. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol 2005; 23: 4866-75.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4866-4875
-
-
Colucci, G.1
Gebbia, V.2
Paoletti, G.3
Giuliani, F.4
Caruso, M.5
Gebbia, N.6
Cartenì, G.7
Agostara, B.8
Pezzella, G.9
Manzione, L.10
Borsellino, N.11
Misino, A.12
-
3
-
-
2942659322
-
Oncogenic potential of the RUNX gene family: 'Overview'
-
Ito Y,. Oncogenic potential of the RUNX gene family: 'Overview'. Oncogene 2004; 23: 4198-208.
-
(2004)
Oncogene
, vol.23
, pp. 4198-4208
-
-
Ito, Y.1
-
4
-
-
0030678549
-
Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
-
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G,. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-54.
-
(1997)
Cell
, vol.89
, pp. 747-754
-
-
Ducy, P.1
Zhang, R.2
Geoffroy, V.3
Ridall, A.L.4
Karsenty, G.5
-
5
-
-
0030684749
-
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
-
Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89: 755-64.
-
(1997)
Cell
, vol.89
, pp. 755-764
-
-
Komori, T.1
Yagi, H.2
Nomura, S.3
Yamaguchi, A.4
Sasaki, K.5
Deguchi, K.6
Shimizu, Y.7
Bronson, R.T.8
Gao, Y.H.9
Inada, M.10
Sato, M.11
Okamoto, R.12
-
6
-
-
0030666372
-
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
-
Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ,. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89: 765-71.
-
(1997)
Cell
, vol.89
, pp. 765-771
-
-
Otto, F.1
Thornell, A.P.2
Crompton, T.3
Denzel, A.4
Gilmour, K.C.5
Rosewell, I.R.6
Stamp, G.W.7
Beddington, R.S.8
Mundlos, S.9
Olsen, B.R.10
Selby, P.B.11
Owen, M.J.12
-
7
-
-
15444351110
-
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
-
Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997; 89: 773-9.
-
(1997)
Cell
, vol.89
, pp. 773-779
-
-
Mundlos, S.1
Otto, F.2
Mundlos, C.3
Mulliken, J.B.4
Aylsworth, A.S.5
Albright, S.6
Lindhout, D.7
Cole, W.G.8
Henn, W.9
Knoll, J.H.10
Owen, M.J.11
Mertelsmann, R.12
-
8
-
-
0042887424
-
Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo
-
Zheng Q, Zhou G, Morello R, Chen Y, Garcia-Rojas X, Lee B,. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol 2003; 162: 833-42.
-
(2003)
J Cell Biol
, vol.162
, pp. 833-842
-
-
Zheng, Q.1
Zhou, G.2
Morello, R.3
Chen, Y.4
Garcia-Rojas, X.5
Lee, B.6
-
9
-
-
70449724816
-
Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells
-
San Martin IA, Varela N, Gaete M, Villegas K, Osorio M, Tapia JC, Antonelli M, Mancilla EE, Pereira BP, Nathan SS, Lian JB, Stein JL, et al. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells. J Cell Physiol 2009; 221: 560-71.
-
(2009)
J Cell Physiol
, vol.221
, pp. 560-571
-
-
San Martin, I.A.1
Varela, N.2
Gaete, M.3
Villegas, K.4
Osorio, M.5
Tapia, J.C.6
Antonelli, M.7
Mancilla, E.E.8
Pereira, B.P.9
Nathan, S.S.10
Lian, J.B.11
Stein, J.L.12
-
10
-
-
70449727683
-
Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1)
-
Pereira BP, Zhou Y, Gupta A, Leong DT, Aung KZ, Ling L, Pho RW, Galindo M, Salto-Tellez M, Stein GS, Cool SM, van Wijnen AJ, et al. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1). J Cell Physiol 2009; 221: 778-88.
-
(2009)
J Cell Physiol
, vol.221
, pp. 778-788
-
-
Pereira, B.P.1
Zhou, Y.2
Gupta, A.3
Leong, D.T.4
Aung, K.Z.5
Ling, L.6
Pho, R.W.7
Galindo, M.8
Salto-Tellez, M.9
Stein, G.S.10
Cool, S.M.11
Van Wijnen, A.J.12
-
11
-
-
0038242432
-
Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function
-
Brubaker KD, Vessella RL, Brown LG, Corey E,. Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function. Prostate 2003; 56: 13-22.
-
(2003)
Prostate
, vol.56
, pp. 13-22
-
-
Brubaker, K.D.1
Vessella, R.L.2
Brown, L.G.3
Corey, E.4
-
12
-
-
35348831090
-
Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer
-
Kayed H, Jiang X, Keleg S, Jesnowski R, Giese T, Berger MR, Esposito I, Löhr M, Friess H, Kleeff J,. Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer. Br J Cancer 2007; 97: 1106-15.
-
(2007)
Br J Cancer
, vol.97
, pp. 1106-1115
-
-
Kayed, H.1
Jiang, X.2
Keleg, S.3
Jesnowski, R.4
Giese, T.5
Berger, M.R.6
Esposito, I.7
Löhr, M.8
Friess, H.9
Kleeff, J.10
-
13
-
-
45149089581
-
Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells
-
Endo T, Ohta K, Kobayashi T,. Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells. J Clin Endocrinol Metab 2008; 93: 2409-12.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 2409-2412
-
-
Endo, T.1
Ohta, K.2
Kobayashi, T.3
-
14
-
-
78449307996
-
Runx2 in human breast carcinoma: Its potential roles in cancer progression
-
Onodera Y, Miki Y, Suzuki T, Takagi K, Akahira J, Sakyu T, Watanabe M, Inoue S, Ishida T, Ohuchi N, Sasano H,. Runx2 in human breast carcinoma: its potential roles in cancer progression. Cancer Sci 2010; 101: 2670-5.
-
(2010)
Cancer Sci
, vol.101
, pp. 2670-2675
-
-
Onodera, Y.1
Miki, Y.2
Suzuki, T.3
Takagi, K.4
Akahira, J.5
Sakyu, T.6
Watanabe, M.7
Inoue, S.8
Ishida, T.9
Ohuchi, N.10
Sasano, H.11
-
15
-
-
33745825137
-
Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells
-
Wai PY, Mi Z, Gao C, Guo H, Marroquin C, Kuo PC,. Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. J Biol Chem 2006; 281: 18973-82.
-
(2006)
J Biol Chem
, vol.281
, pp. 18973-18982
-
-
Wai, P.Y.1
Mi, Z.2
Gao, C.3
Guo, H.4
Marroquin, C.5
Kuo, P.C.6
-
16
-
-
77954167894
-
Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells
-
Georges R, Adwan H, Zhivkova M, Eyol E, Bergmann F, Berger MR,. Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells. Int J Oncol 2010; 37: 249-56.
-
(2010)
Int J Oncol
, vol.37
, pp. 249-256
-
-
Georges, R.1
Adwan, H.2
Zhivkova, M.3
Eyol, E.4
Bergmann, F.5
Berger, M.R.6
-
17
-
-
79957667295
-
Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells
-
Edvardsson K, Ström A, Jonsson P, Gustafsson JÅ, Williams C,. Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells. Mol Endocrinol 2011; 25: 969-79.
-
(2011)
Mol Endocrinol
, vol.25
, pp. 969-979
-
-
Edvardsson, K.1
Ström, A.2
Jonsson, P.3
Gustafsson, J.4
Williams, C.5
-
18
-
-
67649641789
-
Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone
-
Mak IW, Cowan RW, Popovic S, Colterjohn N, Singh G, Ghert M,. Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone. Bone 2009; 45: 377-86.
-
(2009)
Bone
, vol.45
, pp. 377-386
-
-
Mak, I.W.1
Cowan, R.W.2
Popovic, S.3
Colterjohn, N.4
Singh, G.5
Ghert, M.6
-
19
-
-
0027394794
-
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer
-
Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL,. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993; 85: 200-6.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 200-206
-
-
Allred, D.C.1
Clark, G.M.2
Elledge, R.3
Fuqua, S.A.4
Brown, R.W.5
Chamness, G.C.6
Osborne, C.K.7
McGuire, W.L.8
-
20
-
-
0034663421
-
ICI 182,780 (Faslodex): Development of a novel, "pure" antiestrogen
-
Howell A, Osborne CK, Morris C, Wakeling AE,. ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer 2000; 89: 817-25.
-
(2000)
Cancer
, vol.89
, pp. 817-825
-
-
Howell, A.1
Osborne, C.K.2
Morris, C.3
Wakeling, A.E.4
-
21
-
-
0034738653
-
Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards
-
Dumoulin FL, Nischalke HD, Leifeld L, von dem Bussche A, Rockstroh JK, Sauerbruch T, Spengler U,. Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards. J Immunol Methods 2000; 241: 9-19.
-
(2000)
J Immunol Methods
, vol.241
, pp. 9-19
-
-
Dumoulin, F.L.1
Nischalke, H.D.2
Leifeld, L.3
Von Dem Bussche, A.4
Rockstroh, J.K.5
Sauerbruch, T.6
Spengler, U.7
-
22
-
-
33847765402
-
Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: A possible androgenic bone protective effects induced by exemestane
-
Miki Y, Suzuki T, Hatori M, Igarashi K, Aisaki KI, Kanno J, Nakamura Y, Uzuki M, Sawai T, Sasano H,. Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: a possible androgenic bone protective effects induced by exemestane. Bone 2007; 40: 876-87.
-
(2007)
Bone
, vol.40
, pp. 876-887
-
-
Miki, Y.1
Suzuki, T.2
Hatori, M.3
Igarashi, K.4
Aisaki, K.I.5
Kanno, J.6
Nakamura, Y.7
Uzuki, M.8
Sawai, T.9
Sasano, H.10
-
23
-
-
34547806636
-
Early growth responsive gene 3 in human breast carcinoma: A regulator of estrogen-meditated invasion and a potent prognostic factor
-
Suzuki T, Inoue A, Miki Y, Moriya T, Akahira J, Ishida T, Hirakawa H, Yamaguchi Y, Hayashi S, Sasano H,. Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor. Endocr Relat Cancer 2007; 14: 279-92.
-
(2007)
Endocr Relat Cancer
, vol.14
, pp. 279-292
-
-
Suzuki, T.1
Inoue, A.2
Miki, Y.3
Moriya, T.4
Akahira, J.5
Ishida, T.6
Hirakawa, H.7
Yamaguchi, Y.8
Hayashi, S.9
Sasano, H.10
-
24
-
-
70350463894
-
MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells
-
Fang YJ, Pan ZZ, Li LR, Lu ZH, Zhang LY, Wan DS,. MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells. J Exp Clin Cancer Res 2009; 28: 132-9.
-
(2009)
J Exp Clin Cancer Res
, vol.28
, pp. 132-139
-
-
Fang, Y.J.1
Pan, Z.Z.2
Li, L.R.3
Lu, Z.H.4
Zhang, L.Y.5
Wan, D.S.6
-
25
-
-
49249095104
-
Discriminating gene expression profiles of memory B cell subpopulations
-
Ehrhardt GR, Hijikata A, Kitamura H, Ohara O, Wang JY, Cooper MD,. Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med 2008; 205: 1807-17.
-
(2008)
J Exp Med
, vol.205
, pp. 1807-1817
-
-
Ehrhardt, G.R.1
Hijikata, A.2
Kitamura, H.3
Ohara, O.4
Wang, J.Y.5
Cooper, M.D.6
-
26
-
-
70349958032
-
Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
-
Fluge O, Gravdal K, Carlsen E, Vonen B, Kjellevold K, Refsum S, Lilleng R, Eide TJ, Halvorsen TB, Tveit KM, Otte AP, Akslen LA, et al. Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. Br J Cancer 2009; 101: 1282-9.
-
(2009)
Br J Cancer
, vol.101
, pp. 1282-1289
-
-
Fluge, O.1
Gravdal, K.2
Carlsen, E.3
Vonen, B.4
Kjellevold, K.5
Refsum, S.6
Lilleng, R.7
Eide, T.J.8
Halvorsen, T.B.9
Tveit, K.M.10
Otte, A.P.11
Akslen, L.A.12
-
27
-
-
0034643293
-
Estrogen receptor beta mRNA in colon cancer cells: Growth effects of estrogen and genistein
-
Arai N, Strom A, Rafter JJ, Gustafsson JA,. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biophys Res Commun 2000; 270: 425-31.
-
(2000)
Biochem Biophys Res Commun
, vol.270
, pp. 425-431
-
-
Arai, N.1
Strom, A.2
Rafter, J.J.3
Gustafsson, J.A.4
-
28
-
-
10344222094
-
The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5- b] pyridine is a potent oestrogen: A mechanistic basis for its tissue-specific carcinogenicity
-
Lauber SN, Ali S, Gooderham NJ,. The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity. Carcinogenesis 2004; 12: 2509-17.
-
(2004)
Carcinogenesis
, vol.12
, pp. 2509-2517
-
-
Lauber, S.N.1
Ali, S.2
Gooderham, N.J.3
-
29
-
-
72749085530
-
Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer
-
Likui W, Hong W, Shuwen Z,. Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer. J Gastrointest Surg 2010; 14: 74-81.
-
(2010)
J Gastrointest Surg
, vol.14
, pp. 74-81
-
-
Likui, W.1
Hong, W.2
Shuwen, Z.3
-
30
-
-
0035126167
-
Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma
-
Bellone G, Carbone A, Tibaudi D, Mauri F, Ferrero I, Smirne C, Suman F, Rivetti C, Migliaretti G, Camandona M, Palestro G, Emanuelli G, et al. Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma. Eur J Cancer 2001; 37: 224-33.
-
(2001)
Eur J Cancer
, vol.37
, pp. 224-233
-
-
Bellone, G.1
Carbone, A.2
Tibaudi, D.3
Mauri, F.4
Ferrero, I.5
Smirne, C.6
Suman, F.7
Rivetti, C.8
Migliaretti, G.9
Camandona, M.10
Palestro, G.11
Emanuelli, G.12
-
31
-
-
0034914814
-
Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2
-
Zelzer E, Glotzer DJ, Hartmann C, Thomas D, Fukai N, Soker S, Olsen BR,. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 2001; 106: 97-106.
-
(2001)
Mech Dev
, vol.106
, pp. 97-106
-
-
Zelzer, E.1
Glotzer, D.J.2
Hartmann, C.3
Thomas, D.4
Fukai, N.5
Soker, S.6
Olsen, B.R.7
-
32
-
-
25444473106
-
The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion
-
Pratap J, Javed A, Languino LR, van Wijnen AJ, Stein JL, Stein GS, Lian JB,. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol 2005; 25: 8581-91.
-
(2005)
Mol Cell Biol
, vol.25
, pp. 8581-8591
-
-
Pratap, J.1
Javed, A.2
Languino, L.R.3
Van Wijnen, A.J.4
Stein, J.L.5
Stein, G.S.6
Lian, J.B.7
-
33
-
-
3042549099
-
Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells
-
Selvamurugan N, Kwok S, Partridge NC,. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells. J Biol Chem 2004; 279: 27764-73.
-
(2004)
J Biol Chem
, vol.279
, pp. 27764-27773
-
-
Selvamurugan, N.1
Kwok, S.2
Partridge, N.C.3
-
34
-
-
0037843323
-
Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells
-
Barnes GL, Javed A, Waller SM, Kamal MH, Hebert KE, Hassan MQ, Bellahcene A, Van Wijnen AJ, Young MF, Lian JB, Stein GS, Gerstenfeld LC,., Gerstenfeld LC,. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 2003; 63: 2631-7.
-
(2003)
Cancer Res
, vol.63
, pp. 2631-2637
-
-
Barnes, G.L.1
Javed, A.2
Waller, S.M.3
Kamal, M.H.4
Hebert, K.E.5
Hassan, M.Q.6
Bellahcene, A.7
Van Wijnen, A.J.8
Young, M.F.9
Lian, J.B.10
Stein, G.S.11
Gerstenfeld, L.C.12
Gerstenfeld, L.C.13
-
35
-
-
23944475103
-
ERβ isoform expression in colorectal carcinoma: An in vivo and in vitro study of clinicopathological and molecular correlates
-
Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ, Saunders PT,. ERβ isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol 2005; 207: 53-60.
-
(2005)
J Pathol
, vol.207
, pp. 53-60
-
-
Wong, N.A.1
Malcomson, R.D.2
Jodrell, D.I.3
Groome, N.P.4
Harrison, D.J.5
Saunders, P.T.6
-
36
-
-
0034485142
-
Estrogen receptor alpha in human breast cancer: Occurrence and significance
-
Ali S, Coombes RC,. Estrogen receptor alpha in human breast cancer: occurrence and significance. J Mammary Gland Biol Neoplasia 2000; 5: 271-81.
-
(2000)
J Mammary Gland Biol Neoplasia
, vol.5
, pp. 271-281
-
-
Ali, S.1
Coombes, R.C.2
-
37
-
-
68749118305
-
Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer
-
Das K, Leong DT, Gupta A, Shen L, Putti T, Stein GS, van Wijnen AJ, Salto-Tellez M,. Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer. Eur J Cancer 2009; 45; 2239-48.
-
(2009)
Eur J Cancer
, vol.45
, pp. 2239-2248
-
-
Das, K.1
Leong, D.T.2
Gupta, A.3
Shen, L.4
Putti, T.5
Stein, G.S.6
Van Wijnen, A.J.7
Salto-Tellez, M.8
-
38
-
-
77954387472
-
Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells
-
Matsumoto Y, Otsuka F, Takano M, Mukai T, Yamanaka R, Takeda M, Miyoshi T, Inagaki K, Sada KE, Makino H,. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Mol Cell Endocrinol 2010; 325; 118-127.
-
(2010)
Mol Cell Endocrinol
, vol.325
, pp. 118-127
-
-
Matsumoto, Y.1
Otsuka, F.2
Takano, M.3
Mukai, T.4
Yamanaka, R.5
Takeda, M.6
Miyoshi, T.7
Inagaki, K.8
Sada, K.E.9
Makino, H.10
-
39
-
-
0037102121
-
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment
-
Howell A, Robertson JF, Quaresma Albano J, Aschermannova A, Mauriac L, Kleeberg UR, Vergote I, Erikstein B, Webster A, Morris C,. Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment. J Clin Oncol 2002; 20: 3396-403.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3396-3403
-
-
Howell, A.1
Robertson, J.F.2
Quaresma Albano, J.3
Aschermannova, A.4
Mauriac, L.5
Kleeberg, U.R.6
Vergote, I.7
Erikstein, B.8
Webster, A.9
Morris, C.10
-
40
-
-
51649084814
-
Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma
-
Niikawa H, Suzuki T, Miki Y, Suzuki S, Nagasaki S, Akahira J, Honma S, Evans DB, Hayashi S, Kondo T, Sasano H,. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Clin Cancer Res 2008; 14: 4417-26.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4417-4426
-
-
Niikawa, H.1
Suzuki, T.2
Miki, Y.3
Suzuki, S.4
Nagasaki, S.5
Akahira, J.6
Honma, S.7
Evans, D.B.8
Hayashi, S.9
Kondo, T.10
Sasano, H.11
-
41
-
-
0031927404
-
Recent use of hormone replacement therapy and the prevalence of colorectal adenomas
-
Chen MJ, Longnecker MP, Morgenstern H, Lee ER, Frankl HD, Haile RW,. Recent use of hormone replacement therapy and the prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 1998; 7: 227-30.
-
(1998)
Cancer Epidemiol Biomarkers Prev
, vol.7
, pp. 227-230
-
-
Chen, M.J.1
Longnecker, M.P.2
Morgenstern, H.3
Lee, E.R.4
Frankl, H.D.5
Haile, R.W.6
-
42
-
-
62349098202
-
Estrogen receptor-beta as a potential target for colon cancer prevention: Chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats
-
Janakiram NB, Steele VE, Rao CV,. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats. Cancer Prev Res 2009; 2: 52-9.
-
(2009)
Cancer Prev Res
, vol.2
, pp. 52-59
-
-
Janakiram, N.B.1
Steele, V.E.2
Rao, C.V.3
-
43
-
-
59149095121
-
Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: Regulators of intratumoral estrogen concentrations and potent prognostic factors
-
Sato R, Suzuki T, Katayose Y, Miura K, Shiiba K, Tateno H, Miki Y, Akahira J, Kamogawa Y, Nagasaki S, Yamamoto K, Ii T, et al. Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors. Cancer Res 2009; 69: 914-22.
-
(2009)
Cancer Res
, vol.69
, pp. 914-922
-
-
Sato, R.1
Suzuki, T.2
Katayose, Y.3
Miura, K.4
Shiiba, K.5
Tateno, H.6
Miki, Y.7
Akahira, J.8
Kamogawa, Y.9
Nagasaki, S.10
Yamamoto, K.11
Ii, T.12
-
44
-
-
0038579655
-
Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation
-
Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG,. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003; 39: 1251-8.
-
(2003)
Eur J Cancer
, vol.39
, pp. 1251-1258
-
-
Konstantinopoulos, P.A.1
Kominea, A.2
Vandoros, G.3
Sykiotis, G.P.4
Andricopoulos, P.5
Varakis, I.6
Sotiropoulou-Bonikou, G.7
Papavassiliou, A.G.8
-
45
-
-
24644454427
-
Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging
-
Jassam N, Bell SM, Speirs V, Quirke P,. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 2005; 14: 17-21.
-
(2005)
Oncol Rep
, vol.14
, pp. 17-21
-
-
Jassam, N.1
Bell, S.M.2
Speirs, V.3
Quirke, P.4
-
46
-
-
57649124231
-
Expression of estrogen receptor beta in colon cancer progression
-
Castiglione F, Taddei A, Degl'Innocenti DR, Buccoliero AM, Bechi P, Garbini F, Chiara FG, Moncini D, Cavallina G, Marascio L, Freschi G, Gian LT,. Expression of estrogen receptor beta in colon cancer progression. Diagn Mol Pathol 2008; 17: 231-36.
-
(2008)
Diagn Mol Pathol
, vol.17
, pp. 231-236
-
-
Castiglione, F.1
Taddei, A.2
Degl'Innocenti, D.R.3
Buccoliero, A.M.4
Bechi, P.5
Garbini, F.6
Chiara, F.G.7
Moncini, D.8
Cavallina, G.9
Marascio, L.10
Freschi, G.11
Gian, L.T.12
-
47
-
-
78449266131
-
Prognostic impact of ERβ and MMP7 expression on overall survival in colon cancer
-
Fang YJ, Lu ZH, Wang F, Wu XJ, Li LR, Zhang LY, Pan ZZ, Wan DS,. Prognostic impact of ERβ and MMP7 expression on overall survival in colon cancer. Tumour Biol 2010; 31: 651-8.
-
(2010)
Tumour Biol
, vol.31
, pp. 651-658
-
-
Fang, Y.J.1
Lu, Z.H.2
Wang, F.3
Wu, X.J.4
Li, L.R.5
Zhang, L.Y.6
Pan, Z.Z.7
Wan, D.S.8
|